English
简体中文
Total: £ 56.28
Published Date: 2025-09-17 | Pages: 110 | Tables: 102 | Pharma & Healthcare
The global Pharmaceutical Excipients market size was US$ 45080 million in 2024 and is forecast to a readjusted size of US$ 64590 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pharmaceutical Excipients market competitiveness, regional economic performance, and supply chain configurations.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent.
With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.
With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.
The global Pharmaceutical Excipients market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Nanjing Well Pharmaceutical
By Type: (Dominant Segment vs High-Margin Innovation)
Starch and Derivatives
Sucrose
Cellulose and Derivatives
Dextrose
Polyols
Inorganic Salts
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., DowDuPont (FMC) in Europe)
- Emerging Product Trends: Starch and Derivatives adoption vs. Sucrose premiumization
- Demand-Side Dynamics: Oral Formulations growth in China vs. Topical Formulations potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Excipients market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sucrose in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Topical Formulations in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Starch and Derivatives dominance in Europe vs. Sucrose demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Pharmaceutical Excipients Product Scope
1.2 Pharmaceutical Excipients by Type
1.2.1 Global Pharmaceutical Excipients Sales by Type (2020 & 2024 & 2031)
1.2.2 Starch and Derivatives
1.2.3 Sucrose
1.2.4 Cellulose and Derivatives
1.2.5 Dextrose
1.2.6 Polyols
1.2.7 Inorganic Salts
1.2.8 Others
1.3 Pharmaceutical Excipients by Application
1.3.1 Global Pharmaceutical Excipients Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Oral Formulations
1.3.3 Topical Formulations
1.3.4 Parenteral Formulations
1.3.5 Other
1.4 Global Pharmaceutical Excipients Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Excipients Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Excipients Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Excipients Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Excipients Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Excipients Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Excipients Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Excipients Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Excipients Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Excipients Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Excipients Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Excipients Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Excipients Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Excipients Market Size and Prospective (2020-2031)
2.4.4 Japan Pharmaceutical Excipients Market Size and Prospective (2020-2031)
2.4.5 India Pharmaceutical Excipients Market Size and Prospective (2020-2031)
2.4.6 South America Pharmaceutical Excipients Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Excipients Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Excipients Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Excipients Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Excipients Price by Type (2020-2025)
3.2 Global Pharmaceutical Excipients Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Excipients Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Excipients Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Excipients Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Excipients Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Excipients Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Excipients Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Excipients Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Excipients Price by Application (2020-2025)
4.2 Global Pharmaceutical Excipients Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Excipients Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Excipients Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Excipients Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Excipients Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Excipients Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Excipients Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients as of 2024)
5.4 Global Pharmaceutical Excipients Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Excipients, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Excipients, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Excipients, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Excipients Sales by Company
6.1.1.1 North America Pharmaceutical Excipients Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Excipients Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Excipients Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Excipients Sales by Company
6.2.1.1 Europe Pharmaceutical Excipients Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Excipients Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Excipients Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Excipients Sales by Company
6.3.1.1 China Pharmaceutical Excipients Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Excipients Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Excipients Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Excipients Sales by Company
6.4.1.1 Japan Pharmaceutical Excipients Sales by Company (2020-2025)
6.4.1.2 Japan Pharmaceutical Excipients Revenue by Company (2020-2025)
6.4.2 Japan Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pharmaceutical Excipients Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Pharmaceutical Excipients Sales by Company
6.5.1.1 India Pharmaceutical Excipients Sales by Company (2020-2025)
6.5.1.2 India Pharmaceutical Excipients Revenue by Company (2020-2025)
6.5.2 India Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.5.3 India Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.5.4 India Pharmaceutical Excipients Major Customer
6.5.5 India Market Trend and Opportunities
6.6 South America Market: Players, Segments, Downstream and Major Customers
6.6.1 South America Pharmaceutical Excipients Sales by Company
6.6.1.1 South America Pharmaceutical Excipients Sales by Company (2020-2025)
6.6.1.2 South America Pharmaceutical Excipients Revenue by Company (2020-2025)
6.6.2 South America Pharmaceutical Excipients Sales Breakdown by Type (2020-2025)
6.6.3 South America Pharmaceutical Excipients Sales Breakdown by Application (2020-2025)
6.6.4 South America Pharmaceutical Excipients Major Customer
6.6.5 South America Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 DowDuPont (FMC)
7.1.1 DowDuPont (FMC) Company Information
7.1.2 DowDuPont (FMC) Business Overview
7.1.3 DowDuPont (FMC) Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.1.4 DowDuPont (FMC) Pharmaceutical Excipients Products Offered
7.1.5 DowDuPont (FMC) Recent Development
7.2 JRS Pharma
7.2.1 JRS Pharma Company Information
7.2.2 JRS Pharma Business Overview
7.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.2.4 JRS Pharma Pharmaceutical Excipients Products Offered
7.2.5 JRS Pharma Recent Development
7.3 BASF
7.3.1 BASF Company Information
7.3.2 BASF Business Overview
7.3.3 BASF Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.3.4 BASF Pharmaceutical Excipients Products Offered
7.3.5 BASF Recent Development
7.4 Lubrizol
7.4.1 Lubrizol Company Information
7.4.2 Lubrizol Business Overview
7.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Lubrizol Pharmaceutical Excipients Products Offered
7.4.5 Lubrizol Recent Development
7.5 Ashland
7.5.1 Ashland Company Information
7.5.2 Ashland Business Overview
7.5.3 Ashland Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Ashland Pharmaceutical Excipients Products Offered
7.5.5 Ashland Recent Development
7.6 Croda International
7.6.1 Croda International Company Information
7.6.2 Croda International Business Overview
7.6.3 Croda International Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Croda International Pharmaceutical Excipients Products Offered
7.6.5 Croda International Recent Development
7.7 Roquette
7.7.1 Roquette Company Information
7.7.2 Roquette Business Overview
7.7.3 Roquette Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Roquette Pharmaceutical Excipients Products Offered
7.7.5 Roquette Recent Development
7.8 Shin-Etsu
7.8.1 Shin-Etsu Company Information
7.8.2 Shin-Etsu Business Overview
7.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Shin-Etsu Pharmaceutical Excipients Products Offered
7.8.5 Shin-Etsu Recent Development
7.9 Evonik
7.9.1 Evonik Company Information
7.9.2 Evonik Business Overview
7.9.3 Evonik Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Evonik Pharmaceutical Excipients Products Offered
7.9.5 Evonik Recent Development
7.10 Associated British Foods
7.10.1 Associated British Foods Company Information
7.10.2 Associated British Foods Business Overview
7.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Associated British Foods Pharmaceutical Excipients Products Offered
7.10.5 Associated British Foods Recent Development
7.11 Südzucker AG
7.11.1 Südzucker AG Company Information
7.11.2 Südzucker AG Business Overview
7.11.3 Südzucker AG Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Südzucker AG Pharmaceutical Excipients Products Offered
7.11.5 Südzucker AG Recent Development
7.12 Mitsubishi
7.12.1 Mitsubishi Company Information
7.12.2 Mitsubishi Business Overview
7.12.3 Mitsubishi Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Mitsubishi Pharmaceutical Excipients Products Offered
7.12.5 Mitsubishi Recent Development
7.13 Hunan ER-KANG
7.13.1 Hunan ER-KANG Company Information
7.13.2 Hunan ER-KANG Business Overview
7.13.3 Hunan ER-KANG Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Hunan ER-KANG Pharmaceutical Excipients Products Offered
7.13.5 Hunan ER-KANG Recent Development
7.14 Anhui Sunhere
7.14.1 Anhui Sunhere Company Information
7.14.2 Anhui Sunhere Business Overview
7.14.3 Anhui Sunhere Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Anhui Sunhere Pharmaceutical Excipients Products Offered
7.14.5 Anhui Sunhere Recent Development
7.15 Tianjin Chase Sun
7.15.1 Tianjin Chase Sun Company Information
7.15.2 Tianjin Chase Sun Business Overview
7.15.3 Tianjin Chase Sun Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Tianjin Chase Sun Pharmaceutical Excipients Products Offered
7.15.5 Tianjin Chase Sun Recent Development
7.16 Xiwang Group
7.16.1 Xiwang Group Company Information
7.16.2 Xiwang Group Business Overview
7.16.3 Xiwang Group Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Xiwang Group Pharmaceutical Excipients Products Offered
7.16.5 Xiwang Group Recent Development
7.17 ShengTai Group
7.17.1 ShengTai Group Company Information
7.17.2 ShengTai Group Business Overview
7.17.3 ShengTai Group Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.17.4 ShengTai Group Pharmaceutical Excipients Products Offered
7.17.5 ShengTai Group Recent Development
7.18 Nanjing Well Pharmaceutical
7.18.1 Nanjing Well Pharmaceutical Company Information
7.18.2 Nanjing Well Pharmaceutical Business Overview
7.18.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients Products Offered
7.18.5 Nanjing Well Pharmaceutical Recent Development
8 Pharmaceutical Excipients Manufacturing Cost Analysis
8.1 Pharmaceutical Excipients Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Excipients
8.4 Pharmaceutical Excipients Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Excipients Distributors List
9.3 Pharmaceutical Excipients Customers
10 Pharmaceutical Excipients Market Dynamics
10.1 Pharmaceutical Excipients Industry Trends
10.2 Pharmaceutical Excipients Market Drivers
10.3 Pharmaceutical Excipients Market Challenges
10.4 Pharmaceutical Excipients Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Excipients Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Pharmaceutical Excipients Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Pharmaceutical Excipients Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pharmaceutical Excipients Sales (K Tons) by Region (2020-2025)
Table 5. Global Pharmaceutical Excipients Sales Market Share by Region (2020-2025)
Table 6. Global Pharmaceutical Excipients Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Pharmaceutical Excipients Revenue Share by Region (2020-2025)
Table 8. Global Pharmaceutical Excipients Sales (K Tons) Forecast by Region (2026-2031)
Table 9. Global Pharmaceutical Excipients Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Pharmaceutical Excipients Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Pharmaceutical Excipients Revenue Share Forecast by Region (2026-2031)
Table 12. Global Pharmaceutical Excipients Sales by Type (K Tons) & (2020-2025)
Table 13. Global Pharmaceutical Excipients Sales Share by Type (2020-2025)
Table 14. Global Pharmaceutical Excipients Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Pharmaceutical Excipients Price by Type (US$/Ton) & (2020-2025)
Table 16. Global Pharmaceutical Excipients Sales by Type (K Tons) & (2026-2031)
Table 17. Global Pharmaceutical Excipients Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Pharmaceutical Excipients Price by Type (US$/Ton) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Pharmaceutical Excipients Sales by Application (K Tons) & (2020-2025)
Table 21. Global Pharmaceutical Excipients Sales Share by Application (2020-2025)
Table 22. Global Pharmaceutical Excipients Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Pharmaceutical Excipients Price by Application (US$/Ton) & (2020-2025)
Table 24. Global Pharmaceutical Excipients Sales by Application (K Tons) & (2026-2031)
Table 25. Global Pharmaceutical Excipients Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Pharmaceutical Excipients Price by Application (US$/Ton) & (2026-2031)
Table 27. New Sources of Growth in Pharmaceutical Excipients Application
Table 28. Global Pharmaceutical Excipients Sales by Company (K Tons) & (2020-2025)
Table 29. Global Pharmaceutical Excipients Sales Share by Company (2020-2025)
Table 30. Global Pharmaceutical Excipients Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Pharmaceutical Excipients Revenue Share by Company (2020-2025)
Table 32. Global Pharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients as of 2024)
Table 33. Global Market Pharmaceutical Excipients Average Price by Company (US$/Ton) & (2020-2025)
Table 34. Global Key Manufacturers of Pharmaceutical Excipients, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Pharmaceutical Excipients, Product Type & Application
Table 36. Global Key Manufacturers of Pharmaceutical Excipients, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 39. North America Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 40. North America Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 42. North America Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 43. North America Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 44. North America Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 45. North America Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 46. Europe Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 47. Europe Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 48. Europe Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 50. Europe Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 51. Europe Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 52. Europe Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 53. Europe Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 54. China Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 55. China Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 56. China Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 58. China Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 59. China Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 60. China Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 61. China Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 62. Japan Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 63. Japan Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 64. Japan Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 66. Japan Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 67. Japan Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 68. Japan Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 69. Japan Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 70. India Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 71. India Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 72. India Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 74. India Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 75. India Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 76. India Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 77. India Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 78. South America Pharmaceutical Excipients Sales by Company (2020-2025) & (K Tons)
Table 79. South America Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 80. South America Pharmaceutical Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 81. South America Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 82. South America Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
Table 83. South America Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 84. South America Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
Table 85. South America Pharmaceutical Excipients Sales Market Share by Application (2020-2025)
Table 86. DowDuPont (FMC) Company Information
Table 87. DowDuPont (FMC) Description and Business Overview
Table 88. DowDuPont (FMC) Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 89. DowDuPont (FMC) Pharmaceutical Excipients Product
Table 90. DowDuPont (FMC) Recent Development
Table 91. JRS Pharma Company Information
Table 92. JRS Pharma Description and Business Overview
Table 93. JRS Pharma Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 94. JRS Pharma Pharmaceutical Excipients Product
Table 95. JRS Pharma Recent Development
Table 96. BASF Company Information
Table 97. BASF Description and Business Overview
Table 98. BASF Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 99. BASF Pharmaceutical Excipients Product
Table 100. BASF Recent Development
Table 101. Lubrizol Company Information
Table 102. Lubrizol Description and Business Overview
Table 103. Lubrizol Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 104. Lubrizol Pharmaceutical Excipients Product
Table 105. Lubrizol Recent Development
Table 106. Ashland Company Information
Table 107. Ashland Description and Business Overview
Table 108. Ashland Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 109. Ashland Pharmaceutical Excipients Product
Table 110. Ashland Recent Development
Table 111. Croda International Company Information
Table 112. Croda International Description and Business Overview
Table 113. Croda International Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 114. Croda International Pharmaceutical Excipients Product
Table 115. Croda International Recent Development
Table 116. Roquette Company Information
Table 117. Roquette Description and Business Overview
Table 118. Roquette Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 119. Roquette Pharmaceutical Excipients Product
Table 120. Roquette Recent Development
Table 121. Shin-Etsu Company Information
Table 122. Shin-Etsu Description and Business Overview
Table 123. Shin-Etsu Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 124. Shin-Etsu Pharmaceutical Excipients Product
Table 125. Shin-Etsu Recent Development
Table 126. Evonik Company Information
Table 127. Evonik Description and Business Overview
Table 128. Evonik Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 129. Evonik Pharmaceutical Excipients Product
Table 130. Evonik Recent Development
Table 131. Associated British Foods Company Information
Table 132. Associated British Foods Description and Business Overview
Table 133. Associated British Foods Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 134. Associated British Foods Pharmaceutical Excipients Product
Table 135. Associated British Foods Recent Development
Table 136. Südzucker AG Company Information
Table 137. Südzucker AG Description and Business Overview
Table 138. Südzucker AG Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 139. Südzucker AG Pharmaceutical Excipients Product
Table 140. Südzucker AG Recent Development
Table 141. Mitsubishi Company Information
Table 142. Mitsubishi Description and Business Overview
Table 143. Mitsubishi Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 144. Mitsubishi Pharmaceutical Excipients Product
Table 145. Mitsubishi Recent Development
Table 146. Hunan ER-KANG Company Information
Table 147. Hunan ER-KANG Description and Business Overview
Table 148. Hunan ER-KANG Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 149. Hunan ER-KANG Pharmaceutical Excipients Product
Table 150. Hunan ER-KANG Recent Development
Table 151. Anhui Sunhere Company Information
Table 152. Anhui Sunhere Description and Business Overview
Table 153. Anhui Sunhere Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 154. Anhui Sunhere Pharmaceutical Excipients Product
Table 155. Anhui Sunhere Recent Development
Table 156. Tianjin Chase Sun Company Information
Table 157. Tianjin Chase Sun Description and Business Overview
Table 158. Tianjin Chase Sun Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 159. Tianjin Chase Sun Pharmaceutical Excipients Product
Table 160. Tianjin Chase Sun Recent Development
Table 161. Xiwang Group Company Information
Table 162. Xiwang Group Description and Business Overview
Table 163. Xiwang Group Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 164. Xiwang Group Pharmaceutical Excipients Product
Table 165. Xiwang Group Recent Development
Table 166. ShengTai Group Company Information
Table 167. ShengTai Group Description and Business Overview
Table 168. ShengTai Group Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 169. ShengTai Group Pharmaceutical Excipients Product
Table 170. ShengTai Group Recent Development
Table 171. Nanjing Well Pharmaceutical Company Information
Table 172. Nanjing Well Pharmaceutical Description and Business Overview
Table 173. Nanjing Well Pharmaceutical Pharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 174. Nanjing Well Pharmaceutical Pharmaceutical Excipients Product
Table 175. Nanjing Well Pharmaceutical Recent Development
Table 176. Production Base and Market Concentration Rate of Raw Material
Table 177. Key Suppliers of Raw Materials
Table 178. Pharmaceutical Excipients Distributors List
Table 179. Pharmaceutical Excipients Customers List
Table 180. Pharmaceutical Excipients Market Trends
Table 181. Pharmaceutical Excipients Market Drivers
Table 182. Pharmaceutical Excipients Market Challenges
Table 183. Pharmaceutical Excipients Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Excipients Product Picture
Figure 2. Global Pharmaceutical Excipients Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Pharmaceutical Excipients Sales Market Share by Type in 2024 & 2031
Figure 4. Starch and Derivatives Product Picture
Figure 5. Sucrose Product Picture
Figure 6. Cellulose and Derivatives Product Picture
Figure 7. Dextrose Product Picture
Figure 8. Polyols Product Picture
Figure 9. Inorganic Salts Product Picture
Figure 10. Others Product Picture
Figure 11. Global Pharmaceutical Excipients Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 12. Global Pharmaceutical Excipients Sales Market Share by Application in 2024 & 2031
Figure 13. Oral Formulations Examples
Figure 14. Topical Formulations Examples
Figure 15. Parenteral Formulations Examples
Figure 16. Other Examples
Figure 17. Global Pharmaceutical Excipients Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Pharmaceutical Excipients Sales Growth Rate (2020-2031) & (US$ Million)
Figure 19. Global Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 20. Global Pharmaceutical Excipients Price Trends Growth Rate (2020-2031) & (US$/Ton)
Figure 21. Pharmaceutical Excipients Report Years Considered
Figure 22. Global Market Pharmaceutical Excipients Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 23. Global Pharmaceutical Excipients Revenue Market Share by Region: 2020 VS 2024
Figure 24. North America Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. North America Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 26. Europe Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 28. China Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. China Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 30. Japan Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 31. Japan Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 32. India Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 33. India Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 34. South America Pharmaceutical Excipients Revenue (US$ Million) Growth Rate (2020-2031)
Figure 35. South America Pharmaceutical Excipients Sales (K Tons) Growth Rate (2020-2031)
Figure 36. Global Pharmaceutical Excipients Revenue Share by Type (2020-2025)
Figure 37. Global Pharmaceutical Excipients Sales Share by Type (2026-2031)
Figure 38. Global Pharmaceutical Excipients Revenue Share by Type (2026-2031)
Figure 39. Global Pharmaceutical Excipients Revenue Share by Application (2020-2025)
Figure 40. Global Pharmaceutical Excipients Revenue Growth Rate by Application in 2020 & 2024
Figure 41. Global Pharmaceutical Excipients Sales Share by Application (2026-2031)
Figure 42. Global Pharmaceutical Excipients Revenue Share by Application (2026-2031)
Figure 43. Global Pharmaceutical Excipients Sales Share by Company (2024)
Figure 44. Global Pharmaceutical Excipients Revenue Share by Company (2024)
Figure 45. Global 5 Largest Pharmaceutical Excipients Players Market Share by Revenue in Pharmaceutical Excipients: 2020 & 2024
Figure 46. Pharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 47. Manufacturing Cost Structure of Pharmaceutical Excipients
Figure 48. Manufacturing Process Analysis of Pharmaceutical Excipients
Figure 49. Pharmaceutical Excipients Industrial Chain
Figure 50. Channels of Distribution (Direct Vs Distribution)
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
